269 related articles for article (PubMed ID: 30791960)
1. Late-onset megaconial myopathy in mice lacking group I Paks.
Joseph GA; Hung M; Goel AJ; Hong M; Rieder MK; Beckmann ND; Serasinghe MN; Chipuk JE; Devarakonda PM; Goldhamer DJ; Aldana-Hernandez P; Curtis J; Jacobs RL; Krauss RS
Skelet Muscle; 2019 Feb; 9(1):5. PubMed ID: 30791960
[TBL] [Abstract][Full Text] [Related]
2. The p21-activated kinase 2 (PAK2), but not PAK1, regulates contraction-stimulated skeletal muscle glucose transport.
Møller LLV; Nielsen IL; Knudsen JR; Andersen NR; Jensen TE; Sylow L; Richter EA
Physiol Rep; 2020 Jun; 8(12):e14460. PubMed ID: 32597567
[TBL] [Abstract][Full Text] [Related]
3. Group I Paks Promote Skeletal Myoblast Differentiation In Vivo and In Vitro.
Joseph GA; Lu M; Radu M; Lee JK; Burden SJ; Chernoff J; Krauss RS
Mol Cell Biol; 2017 Feb; 37(4):. PubMed ID: 27920252
[TBL] [Abstract][Full Text] [Related]
4. Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle.
Møller LLV; Jaurji M; Kjøbsted R; Joseph GA; Madsen AB; Knudsen JR; Lundsgaard AM; Andersen NR; Schjerling P; Jensen TE; Krauss RS; Richter EA; Sylow L
J Physiol; 2020 Dec; 598(23):5351-5377. PubMed ID: 32844438
[TBL] [Abstract][Full Text] [Related]
5. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
[TBL] [Abstract][Full Text] [Related]
6. Potential compensation among group I PAK members in hindlimb ischemia and wound healing.
Elsherif L; Ozler M; Zayed MA; Shen JH; Chernoff J; Faber JE; Parise LV
PLoS One; 2014; 9(11):e112239. PubMed ID: 25379771
[TBL] [Abstract][Full Text] [Related]
7. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
[TBL] [Abstract][Full Text] [Related]
8. Functional rescue in a mouse model of congenital muscular dystrophy with megaconial myopathy.
Sayed-Zahid AA; Sher RB; Sukoff Rizzo SJ; Anderson LC; Patenaude KE; Cox GA
Hum Mol Genet; 2019 Aug; 28(16):2635-2647. PubMed ID: 31216357
[TBL] [Abstract][Full Text] [Related]
9. PAK1 and PAK2 in cell metabolism regulation.
Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
[TBL] [Abstract][Full Text] [Related]
10. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
Sun X; Su VL; Calderwood DA
J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
[TBL] [Abstract][Full Text] [Related]
11. Reduced mitochondrial fission and impaired energy metabolism in human primary skeletal muscle cells of Megaconial Congenital Muscular Dystrophy.
Aksu-Menges E; Eylem CC; Nemutlu E; Gizer M; Korkusuz P; Topaloglu H; Talim B; Balci-Hayta B
Sci Rep; 2021 Sep; 11(1):18161. PubMed ID: 34518586
[TBL] [Abstract][Full Text] [Related]
12. Novel CHKB mutation expands the megaconial muscular dystrophy phenotype.
Cabrera-Serrano M; Junckerstorff RC; Atkinson V; Sivadorai P; Allcock RJ; Lamont P; Laing NG
Muscle Nerve; 2015 Jan; 51(1):140-3. PubMed ID: 25187204
[TBL] [Abstract][Full Text] [Related]
13. Muscle choline kinase beta defect causes mitochondrial dysfunction and increased mitophagy.
Mitsuhashi S; Hatakeyama H; Karahashi M; Koumura T; Nonaka I; Hayashi YK; Noguchi S; Sher RB; Nakagawa Y; Manfredi G; Goto Y; Cox GA; Nishino I
Hum Mol Genet; 2011 Oct; 20(19):3841-51. PubMed ID: 21750112
[TBL] [Abstract][Full Text] [Related]
14. Congenital megaconial myopathy due to a novel defect in the choline kinase Beta gene.
Gutiérrez Ríos P; Kalra AA; Wilson JD; Tanji K; Akman HO; Area Gómez E; Schon EA; DiMauro S
Arch Neurol; 2012 May; 69(5):657-61. PubMed ID: 22782513
[TBL] [Abstract][Full Text] [Related]
15. p21-Activated protein kinases and their emerging roles in glucose homeostasis.
Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E707-22. PubMed ID: 24368667
[TBL] [Abstract][Full Text] [Related]
16. PAK1 and PAK2 have different roles in HGF-induced morphological responses.
Bright MD; Garner AP; Ridley AJ
Cell Signal; 2009 Dec; 21(12):1738-47. PubMed ID: 19628037
[TBL] [Abstract][Full Text] [Related]
17. A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis.
Sher RB; Aoyama C; Huebsch KA; Ji S; Kerner J; Yang Y; Frankel WN; Hoppel CL; Wood PA; Vance DE; Cox GA
J Biol Chem; 2006 Feb; 281(8):4938-48. PubMed ID: 16371353
[TBL] [Abstract][Full Text] [Related]
18. Megaconial muscular dystrophy caused by mitochondrial membrane homeostasis defect, new insights from skeletal and heart muscle analyses.
Vanlander AV; Muiño Mosquera L; Panzer J; Deconinck T; Smet J; Seneca S; Van Dorpe J; Ferdinande L; Ceuterick-de Groote C; De Jonghe P; Van Coster R; Baets J
Mitochondrion; 2016 Mar; 27():32-8. PubMed ID: 26855408
[TBL] [Abstract][Full Text] [Related]
19. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
[TBL] [Abstract][Full Text] [Related]
20. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).
Hawley E; Gehlhausen J; Karchugina S; Chow HY; Araiza-Olivera D; Radu M; Smith A; Burks C; Jiang L; Li X; Bessler W; Masters A; Edwards D; Burgin C; Jones D; Yates C; Clapp DW; Chernoff J; Park SJ
Hum Mol Genet; 2021 Aug; 30(17):1607-1617. PubMed ID: 34075397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
